Tech Company Financing Transactions

Metagenomi Funding Round

Metagenomi closed a $175 million Series B financing round on 2/2/2022. Backers included Farallon Capital Management, Partner Fund Management and Bristol-Myers Squibb.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

5980 Horton St. 600
Emeryville, CA 94608
USA

Phone

Undisclosed

Website

www.metagenomi.co

Email Address

Not Recorded

Overview

Founded in 2018 by lead metagenomics researchers at UC Berkeley, Brian C. Thomas and Jillian Banfield, Metagenomi is committed to changing the landscape of cell and gene therapies. By using metagenomics to unlock 4 billion years of microbial evolution, Metagenomi is rapidly identifying and characterizing novel nucleases with unique gene editing capabilities.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Brian Thomas

        

Chief Operating Officer

Jian Irish

        

VP - Bus. Development

Jak Knowles

        

VP - R & D

Alan Brooks

        

Browse more venture capital transactions:

Prev: 2/2/2022: Logixboard venture capital transaction
Next: 2/2/2022: TRLab venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary